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Abstract  
 
Background： The purpose of this study is to evaluate the efficiency and safety of sodium aescinate injection for 
treating children suffering transplanted flap in children hand or foot.  
Materials and Methods： Ninety children patients with transplanted cutaneous nerve nutrition vascular flaps in hand 
or foot were selected and divided into “treatment” and “control” groups randomly by computer. The treatment group 
was prescribed intravenous sodium aescine injection and conventional therapy. The control group was only offered 
conventional therapy. Seven days following treatment, cumulative wound drainage, swelling of flap and adverse 
reactions were recorded. One month subsequent to treatment, two-point discrimination of flap was recorded. At the 
outset of treatment (0-d) and 1, 3, 7-days following treatment, the concentrations of C-reactive protein (CRP) and 
malondialdehyde(MDA) in venous blood were tested. 
Results： At the outset of treatment, there was no statistically significant difference between the two groups in terms of 
CRP and MDA (P>0.05). At 3 and 7 day intervals following treatment, the concentrations of CRP and MDA in 
treatment group were lower than those in control group (P<0.05). The treatment Group’s wound drainage, swelling of 
flap and two-point discrimination of flap was better than those recorded in control group (P<0.05).  
Conclusion： Sodium aescine injection can improve the concentrations of CRP and MDA in venous blood, reduce 
wound drainage, and promote flap sensory recovery. This has an effective and safe application for treating children 
with swelling in their hands or feet. 
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Abbreviations: CRP, C-reactive protein; MDA, malondialdehyde; ATP, adenosine triphosphate. 
  
Introduction 
Children's tissue injuries of their hands or feet are common during emergency. The selected flap with a similar 
tissue structure of hand or foot is used to repair the defect. This not only reconstructs the function, but also restores its 
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normal appearance, which is beneficial to the early recovery and long-term adaptability of children (Wei et al., 2013; 
Wei et al., 2014c; Wei et al., 2015).
 
Flap is the most common and effective method in repairing orthopedic deformities 
and tissue defect. Yet, the ischemia-reperfusion injury often occurs after flap transplant. This can cause partial or total 
flap necrosis, and seriously affects the surgical outcome (Harder et al., 2008). Therefore, during the postoperative 
period, the effective medicine for preventing the occurrence of complications, and promoting flap survival should be 
given priority and be taken seriously. 
Sodium aescinate is extracted from Borneo sub-dried seeds, which is a natural plant. It has a significant effect on 
anti-inflammatory, anti-exudative and reducing swelling (Matsuda et al., 1997). Sodium aescine restores normal 
capillary permeability, increases venous tension, and improves microcirculation. Sodium aescine also has a strong 
affinity for scavenging free radicals. It has a phenolic hydroxy in its molecular structure, which explains why it attracts 
scavenging oxygen free radicals. Sodium aescine was originally prescribed for treating cerebral edema with satisfactory 
results (Mingrino et al., 1978; Rivano et al., 1969). Presently, it has been widely applied for the treating a wide 
assortment of swelling caused by trauma
 
, burns and surgery(Zhang et al., 2012), and likewise venous reflux disorders
 
(Siebert et al., 2002; Carrasco et al., 2007; Raffetto et al., 2011). 
There are scant reports regarding sodium aescine in treating children’s diseases. The purpose of this study is to 
verify the efficacy of sodium aescine for improving swelling, draining and sensory ability in children following flap 
transplants and evaluate the safety of this drug in treating children patients.  
 
Materials and Methods 
General information   
 
From January 2010 to December 2013, 90 children with tissue defects in hand or foot were selected. Tissue 
defects were repaired using cutaneous nerve nutrition vascular flaps, and surgical procedures were approved by senior 
professional doctors. Sample Group consisted of 49 males and 41 females ranging in age from 5 to 14 years old. 
Sixty-two children had hand injuries while twenty-eight children had foot injuries. Fifteen children were treated using 
flap surgery electively and seventy-five children treated using flap during emergency. These children patients were 
assigned numbers according to the time they admitted. Again these groups were sub-divided into treatment and control 
groups by computer-generated random selection. Their distribution ratio was 1: 1, 45 children in each group. There was 
no statistically significant difference regarding cutaneous nerve nutrition vascular flap nor statistically significant 
differences in terms of gender, age, time of injury, surgery, trauma site, damage severity, location (left or right) etc.. 
Lastly there was no statistically significant difference in terms of surgeon’s work experience or professional title. 
 
Exclusion criteria 
 
All children had not had any dehydration medicines in recent one week or any glucocorticoid medicines in the 
most recent month. Excluded children were those with heart disease, previous heart surgeries, kidney damage, kidney 
failure, renal insufficiency, hepatic insufficiency, acquired immunodeficiency virus (HIV) infections, abnormal clotting 
condition, water electrolyte imbalance and insufficient blood circulation.  
 
Ethical considerations 
 
All children and their parents signed a consent form for participating in this study. This research was approved by 
the Medical Reproductive Ethics Committee of authors' Hospital. 
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Intervention 
 
The children with tissue defects in their hands or feet were prescribed conventional therapy. Following flap 
transplantation, homeostasis and analgesia, anti-infection, nutritional support, maintaining water and electrolyte 
balance treatment were measured. The treatment group was given an additional sodium aescine injection (Shandong 
Luye Pharmaceutical Co., Ltd., Shandong, China) one day following transplantation (within 24 hr), dosage of sodium 
aescine injected according to body weight being 0.2 mg / kg, which dissolved in 250ml 0.9% sodium chloride injection. 
Maximum daily dose did not exceed 20mg. This continued once per day, 7 days for a full course of treatment.  
 
Variable assessed  
 
At the outset of treatment (within 24 hours) and at 1, 3, 7-days following treatment, C-reactive protein (CRP) and 
malondialdehyde (MDA) in venous blood were tested. Seven days after treatment, cumulative wound drainage, the 
swelling of flap and adverse reactions were recorded. One month after treatment, two-point discrimination of flap was 
recorded during the follow-up. CRP was tested by automatic biochemical analyzer. MDA was determined by 
thiobarbituric method. Cumulative wound drainage (7 days) included direct wound drainage volume and the amount of 
fluid intake gauze, the amount of fluid intake gauze bases on area or volume of infiltration.  
 
Two-point discrimination test  
 
All child patients had the purpose and methodology explained to them before testing obtaining and getting their 
cooperation. During testing, the examiner fixed the patient’s limbs and instructed them to close their eyes. While the 
two needle detectors were descending, the patient was required to indicate when one or two points were felt- quickly. 
As the distance between these two detectors decreased, patient was required to state when the two points could not be 
properly distinguished. Replying correctly more than seven of ten times test was accepted as the correct resolution, the 
minimum distance at this test is the two-point discrimination detection value
 
(Zhang et al., 2005). 
 
Swelling criteria  
 
With reference to swelling
 
(Liao et al., 2009), 0 degree of swelling is when the skin of flap has no swelling, striae 
of skin exists and elasticity of skin is normal. I degree of swelling is when there is mild swelling of flap compared to 
normal skin, but there are still sticks and swelling center height ≤ 0.5 cm compared with contralateral normal limb. II 
degree of swelling is when skin tension increases, striae of skin disappears, but no blisters and swelling center height is 
in 0.5 to 1cm compared with contralateral normal limb. III degree of swelling is when skin of flap has significant 
swelling, tension blisters, swelling center height ≥ l cm compared with contralateral normal limb.  
 
Safety evaluation  
 
All patients were involved with safety. Adverse effects were recorded and included dizziness, palpitation, nausea, 
diarrhea and skin allergies. Other indicators were tested before and after treatment- primarily liver function, kidney 
function, electrolytes, urine, stool routine and others.  
 
Statistical analysis  
Statistical software SPSS17.0 (SPSS software Inc., USA) was used to analyze data. Measurement data was 
presented as (mean ± standard deviation). T test was used for two groups. The x
2
 test was used to analyze numeration 
data. The Mann-Whitney test was used for non- parametric. P<0.05 was regarded as denoting statistically significant 
difference. 
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Results 
Comparison of basic characteristics 
 
All child patients completed this study. There was no statistically significant difference (P>0.05) between the two 
groups in terms of sex (Male/Female), age, trauma site (Hand/Foot) and location(Left/Right). Seven days after 
treatment, the drainage volume of wound and swelling of flap in the treatment group was better than those in the 
control group and statistical differences were significant (P<0.05). One month after treatment, two-point discrimination 
of flap in treatment group was better than that in the control group, this difference being statistically significant (P<0.05) 
as provided in Table 1. 
 
Table 1: The basic characteristics in two groups  
Group 
Sex 
(cases) Age（ ±s, 
years old） 
Location 
(cases) 
Site (cases) 
Drainage 
volume (ml) 
Two-point 
discrimination 
(mm) 
Swelling 
(cases)  
Male / 
Female 
Left / Right Hand / Foot 
0/ I / II / III 
Control  26/19 9.10±2.80 20/25 30/15 72.25±22.70 9.73±3.68 2/20/22/1  
Treatment 23/22 9.30±2.71 17/28 32/13 58.11±20.51 7.46±3.74 7/25/13/0 
x
2
 /t/Z 
p-value 
x
2
=0.403 
p=0.525 
  t=0.344 
 p=0.732 
x
2
=0.413 
 p=0.520 
x
2
=0.207 
 p=0.649 
  t=2.881, 
p=0.005 
t=2.902 
 p=0.004 
Z=2.471 
p=0.013 
 
Comparison of CRP 
 
At the outset of treatment (0-d), there was no statistically significant difference between the two groups in term of 
CRP (t0=0.997, P>0.05). One day following treatment, the concentrations of CRP in both groups rose to a peak. 
Likewise the CRP declined between 3 to 7-days following treatment, Concentrations of CRP in the treatment group 
were again lower than those in the control group (t1=3.272, t3=8.597, t7=8.003, P<0.05). As shown in Figure 1. 
 
Figure 1: Comparison of CRP in two groups 
Note: All children patients with tissue defects in their hands or feet were prescribed conventional therapy after flap 
transplantation. This included hemostasis and analgesia, anti-infection, nutritional support, maintaining water and 
electrolyte balance treatment. The treatment group was given an additional sodium aescine injection for 7 days (0.2 mg 
/ kg, it dissolved in 250ml 0.9% sodium chloride injection). The maximum daily dosage did not exceed 20mg, once a 
day. The unit of CRP is mg/L 
 
Comparison of MDA  
At the beginning of treatment (0-d), there was no statistically significant difference between the two groups in 
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term of MDA (t 0=0.112, P>0.05). One day following treatment, the concentrations of MDA in two groups rose to their 
peak and later the MDA declined between 3 to 7-days following treatment. The concentrations of MDA in treatment 
group were lower than those in control group (t1=9.569, t3=10.046, t7=7.420, P<0.05). As shown in Figure 2. 
 
Figure 2: Comparisons of MDA in two groups. 
Note: All subjects with tissue defects in their hands or feet were prescribed conventional therapy after flap 
transplantation. This consisted of homeostasis and analgesia, anti-infection, nutritional support, maintaining water and 
electrolyte balances. The treatment group was provided an additional sodium aescine injection for 7 days ( 0.2 mg / kg, 
it dissolved in 250ml 0.9% sodium chloride injection). The maximum daily dosage did not exceed 20mg. The unit of 
MDA is nmol/mL. 
 
Safety Evaluation  
 
There were no adverse reactions such as dizziness, palpitation, nausea, diarrhea and skin allergies in either group. 
There was no liver malfunctioning, kidney failure or electrolyte imbalance and abnormal urine and stool routine. One 
child patient in the treatment group had local irritation pain while the intravenous medicine was dripping. However, 
after slowing the injection rate, these symptoms disappeared. Intravenous injection rate should be 15 to 30 drops/min, 
and the initial infusion rate should be slightly slower. There was no statistically significant difference between these 
two groups in terms of the safety (P>0.05). 
 
Discussion 
 
Soft tissue defects in children’s hands or feet were oftentimes accompanied by damage to the tendon and/or bones. 
If these injuries are not handled properly, it will affect the development and function of the hands and feet. Children are 
at the growing and maturing stage and consequently   preserving limb length and restoring function is the basic 
prerequisite for treatment (Wei et al., 2014a; Wei et al., 2014b). Since children have small hands and feet, these tissues 
have a limited ability for transplanting and this likewise requires consummate repair technology. Choosing the 
appropriate flap is conducive to body function recovery and is helpful for restoring function and purpose. During flap 
grafting, the stimulated wounds produce an inflammatory response and accordingly such mediums as bradykinin, 
histamine and interleukin are released resulting in the edema of flap and the exudation of wound. Following surgery, an 
ischemic reperfusion type injury of flap can infuse an increased rate release of inflammatory mediators and oxygen free 
radicals. This then directly aggravates the tissue damage. An open wound accompanied with severe swelling of flap can 
lead directly to flap occurred necrosis. Therefore, treatment priorities following flap transplantation is the timely 
elimination of inflammatory mediators and free radicals, lifting the edema of flap and improving micro-circulation.  
Sodium aescinate is the sodium salt of triterpenoid saponins with multi ester bond. It has the effects of 
anti-inflammatory, improving swelling and scavenging oxygen free radicals. This has been widely applied in the 
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clinical treatment of various forms of etiologies edema (Fu et al., 2005; Wang et al., 2011). The metabolism of Sodium 
aescinate with its effects of anti-inflammatory and improving edematous was similar to adreno cortico hormones 
(Zhang et al., 2012; Wang et al., 2013). Sodium aescinate increases capillary permeability, improves local 
micro-circulation, increases vein circulation while effectively eliminating local tissue edema. It also has a strong role of 
scavenging oxygen free radicals, thereby reducing its harmful effects on tissue while thus realizing neuroprotection. 
Other related studies have concluded that sodium aescinate reduces denosine triphosphate (ATP) in cellular under 
hypoxic conditions, and maintains the function of cell permeability, thereby alleviating the impact of injury on tissues 
and cells (Kang et al., 2013; Janssens et al., 2000).  
CRP is acute phase proteins compounded by liver cells when the body is subjected to microbial invasion or when 
tissue is stimulated by inflammatory mediators. Under normal circumstances, it is a trace protein in either serum or 
plasma. CRP is a very sensitive indicator in assessing tissue damage and infection (Sierra et al., 2004). Research 
indicates when concentrations of CRP are positive related to cell damage and concentrations of CRP were greater in 
more serious injuries (Li et al., 2008). During flap transplantations, involving both operational and traumatic stress, 
systemic inflammatory responses in children were accordingly aggravated. CRP was marker of trauma and 
inflammation so consequently the concentration of CRP increased following surgery. The major active compound in 
extracts from horse chestnut (Aesculus hippocastanum), has shown clinically significant anti-inflammatory activity 
(Sirtori, 2001; Huang et al., 2015; Wang et al., 2009).
 
The concentrations of CRP in treatment group were lower than 
those in control group. 
Oxygen free radicals have a strong oxidation resistance. This acts on the various components of the cell, leading to 
lipid peroxidation. The end product of lipid peroxidation is MDA. Therefore, the concentration of a body’s MDA 
reflects the extent of lipid peroxidation. Under normal physiological conditions, there is only a small amount of oxygen 
free radicals in the body. Since antioxidant enzymes and antioxidants can remove excess oxygen free radicals- 
Ischemia-reperfusion injuries usually occurs after flap transplantation. An increased amount of oxygen free radicals are 
produced causing serious damage to the body’s normal cells and tissues. Some research purports that sodium aescinate 
has protective effects on ischemic reperfusion in adults, and can reduce levels of free radicals (Yang et al., 2011). At 1, 
3, and 7-days following treatment, concentrations of MDA in the treatment group were lower than the control group (P 
< 0.05). In this study, these results again indicated sodium aescinate’s role in scavenging oxygen free radicals in 
children, the outcomes were consistent with other clinical and animal experiment (Wang et al., 2012; Wei et al., 2011).  
In this study, drainage of wound and swelling of flap in treatment group were better than those in control group 
and these differences were statistically significant (P<0.05).Sodium aescinate’s ability as being anti-leakage and 
suppressing swelling. A Two-point discrimination test for a treatment group having better results than the control group 
ca\n be interpreted as sodium aescinate removing excess oxygen free radicals. This reduces the damage caused by 
inflammation factors and oxygen free radicals and therein promoted neurological recovery of skin flap and the swelling 
of flap resulting in faster recovery.  
Generally, sodium aescinate is prudently dispensed to children. Recently however, it has been generally 
recommended for treating children related diseases. The safety of treatment group was parallel to that of the control 
group and sodium aescinate was dispensed cautiously to children with security. When this medicine is prescribed to 
children, the rate of injection must be controlled and the dosage should be adjusted according to the child’s weight and 
likewise avoiding the medicine being injected into the subcutaneous. 
 
Conclusion 
 
Sodium aescinate can improve the concentrations of both CRP and MDA in children's venous blood, reducing 
wound drainage, and promoting early sensory recovery of the flap. It has an effective and safe application for treating 
children with swelling in their hands or feet. 
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